Universal Influenza Vaccine: mRNA and Nanoparticle Platforms Target Conserved Stalk for Broad Protection
Medical researchers are developing a universal influenza vaccine using mRNA and nanoparticle platforms to target the con...
Read More →Medical researchers are developing a universal influenza vaccine using mRNA and nanoparticle platforms to target the con...
Read More →Artificial intelligence is revitalizing antibiotic discovery by identifying novel molecular scaffolds and designing new ...
Read More →Medical researchers have successfully transplanted 10-gene edited pig kidneys into human recipients, overcoming the hist...
Read More →Verve Therapeutics' in vivo CRISPR base editing program, VERVE-102, utilizes lipid nanoparticles to permanently disable ...
Read More →Landmark trials like SELECT and FLOW have proven that GLP-1 agonists offer profound cardiovascular and renal protection,...
Read More →mRNA-4157/V940, a personalized neoantigen therapy developed by Moderna and Merck, has demonstrated a 44% reduction in re...
Read More →The p-tau217 blood biomarker test has revolutionized Alzheimer’s diagnosis, offering over 90% accuracy and replacing c...
Read More →Pfizer and BioNTech have acquired Catalent’s biologics division for $14B to secure the critical manufacturing capacity...
Read More →Lockheed Martin and SpaceX have secured a $35B joint contract to build the Cislunar Logistics Network, merging defense e...
Read More →NextEra Energy has signed a historic $22B Power Purchase Agreement with tech giants to finance the construction of dedic...
Read More →The European Commission has levied a $6B antitrust fine on the Hyperscaler Consortium for colluding to restrict AI compu...
Read More →Blackstone has acquired a $30B portfolio of data center real estate from Digital Realty Trust, marking a massive institu...
Read More →